SK286978B6 - Použitie jednoreťazcovej protilátky schopnej špecificky viazať epitop prítomný v C-koncovej oblasti proteínu p53 medzi zvyškami 320-393 a nukleovej kyseliny kódujúcej takúto protilátku na prípravu farmaceutickej kompozície na liečbu rakovín - Google Patents
Použitie jednoreťazcovej protilátky schopnej špecificky viazať epitop prítomný v C-koncovej oblasti proteínu p53 medzi zvyškami 320-393 a nukleovej kyseliny kódujúcej takúto protilátku na prípravu farmaceutickej kompozície na liečbu rakovín Download PDFInfo
- Publication number
- SK286978B6 SK286978B6 SK558-99A SK55899A SK286978B6 SK 286978 B6 SK286978 B6 SK 286978B6 SK 55899 A SK55899 A SK 55899A SK 286978 B6 SK286978 B6 SK 286978B6
- Authority
- SK
- Slovakia
- Prior art keywords
- protein
- nucleic acid
- vector
- use according
- ser
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9613176A FR2755144B1 (fr) | 1996-10-29 | 1996-10-29 | Fragments d'anticorps a chaine unique anti-p53 et utilisation |
PCT/FR1997/001921 WO1998018825A1 (fr) | 1996-10-29 | 1997-10-27 | Fragments d'anticorps a chaine unique anti-p53 et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
SK55899A3 SK55899A3 (en) | 2000-06-12 |
SK286978B6 true SK286978B6 (sk) | 2009-08-06 |
Family
ID=9497134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK558-99A SK286978B6 (sk) | 1996-10-29 | 1997-10-27 | Použitie jednoreťazcovej protilátky schopnej špecificky viazať epitop prítomný v C-koncovej oblasti proteínu p53 medzi zvyškami 320-393 a nukleovej kyseliny kódujúcej takúto protilátku na prípravu farmaceutickej kompozície na liečbu rakovín |
Country Status (21)
Country | Link |
---|---|
US (1) | US6852509B1 (ko) |
EP (1) | EP0941252B1 (ko) |
JP (1) | JP4371178B2 (ko) |
KR (1) | KR100874789B1 (ko) |
AT (1) | ATE380198T1 (ko) |
AU (1) | AU745530B2 (ko) |
BR (1) | BR9712575A (ko) |
CA (1) | CA2268865C (ko) |
CZ (1) | CZ300526B6 (ko) |
DE (1) | DE69738352T2 (ko) |
DK (1) | DK0941252T3 (ko) |
ES (1) | ES2297853T3 (ko) |
FR (1) | FR2755144B1 (ko) |
HU (1) | HU226330B1 (ko) |
IL (2) | IL129476A0 (ko) |
NO (1) | NO326452B1 (ko) |
PT (1) | PT941252E (ko) |
SI (1) | SI0941252T1 (ko) |
SK (1) | SK286978B6 (ko) |
WO (1) | WO1998018825A1 (ko) |
ZA (1) | ZA979738B (ko) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL121041A0 (en) * | 1997-06-09 | 1997-11-20 | Yeda Res & Dev | Immunogenic compositions for induction of anti-tumor immunity |
US7199809B1 (en) | 1998-10-19 | 2007-04-03 | Symyx Technologies, Inc. | Graphic design of combinatorial material libraries |
AUPP932199A0 (en) * | 1999-03-19 | 1999-04-15 | St Vincent's Hospital Sydney Limited | Anti-p53 antibodies |
AU769679B2 (en) * | 1999-03-19 | 2004-01-29 | St Vincent's Hospital Sydney Limited | Anti-p53 antibodies |
DE19962583A1 (de) * | 1999-12-23 | 2001-06-28 | Mueller Hermelink Hans Konrad | Antikörper gegen Plasmazellen |
US6630584B1 (en) * | 2000-03-16 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Single chain antibody against mutant p53 |
WO2005061001A1 (ja) * | 2003-12-24 | 2005-07-07 | Locomogene, Inc. | 癌の抑制方法 |
JPWO2005061007A1 (ja) * | 2003-12-24 | 2007-07-12 | 学校法人 聖マリアンナ医科大学 | 癌の抑制方法 |
GB0420771D0 (en) * | 2004-09-17 | 2004-10-20 | Randox Lab Ltd | Antibody |
US8039594B2 (en) | 2005-03-25 | 2011-10-18 | Ramot At Tel-Aviv University Ltd. | Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses |
WO2007028117A2 (en) * | 2005-09-02 | 2007-03-08 | New England Medical Center Hospitals, Inc. | P8 as a marker for heart failure |
EP3452508A1 (en) * | 2016-05-02 | 2019-03-13 | Prothena Biosciences Limited | Antibodies recognizing tau |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224784D0 (en) * | 1992-11-26 | 1993-01-13 | Univ Dundee | Cellular protein |
FR2732348B1 (fr) * | 1995-03-31 | 1997-04-30 | Rhone Poulenc Rorer Sa | Systeme d'expression conditionnel |
FR2736915B1 (fr) | 1995-07-19 | 1997-08-22 | Rhone Poulenc Rorer Sa | Variants de la proteine p53 et utilisations therapeutiques |
-
1996
- 1996-10-29 FR FR9613176A patent/FR2755144B1/fr not_active Expired - Fee Related
-
1997
- 1997-10-27 IL IL12947697A patent/IL129476A0/xx unknown
- 1997-10-27 WO PCT/FR1997/001921 patent/WO1998018825A1/fr active IP Right Grant
- 1997-10-27 HU HU9904199A patent/HU226330B1/hu not_active IP Right Cessation
- 1997-10-27 EP EP97912262A patent/EP0941252B1/fr not_active Expired - Lifetime
- 1997-10-27 DE DE69738352T patent/DE69738352T2/de not_active Expired - Lifetime
- 1997-10-27 ES ES97912262T patent/ES2297853T3/es not_active Expired - Lifetime
- 1997-10-27 KR KR1019997003679A patent/KR100874789B1/ko not_active IP Right Cessation
- 1997-10-27 PT PT97912262T patent/PT941252E/pt unknown
- 1997-10-27 BR BR9712575-0A patent/BR9712575A/pt not_active Application Discontinuation
- 1997-10-27 SK SK558-99A patent/SK286978B6/sk not_active IP Right Cessation
- 1997-10-27 CA CA2268865A patent/CA2268865C/fr not_active Expired - Fee Related
- 1997-10-27 SI SI9730778T patent/SI0941252T1/sl unknown
- 1997-10-27 US US09/297,181 patent/US6852509B1/en not_active Expired - Fee Related
- 1997-10-27 AU AU49520/97A patent/AU745530B2/en not_active Ceased
- 1997-10-27 DK DK97912262T patent/DK0941252T3/da active
- 1997-10-27 CZ CZ0145599A patent/CZ300526B6/cs not_active IP Right Cessation
- 1997-10-27 JP JP52011998A patent/JP4371178B2/ja not_active Expired - Fee Related
- 1997-10-27 AT AT97912262T patent/ATE380198T1/de active
- 1997-10-29 ZA ZA9709738A patent/ZA979738B/xx unknown
-
1999
- 1999-04-13 NO NO19991729A patent/NO326452B1/no not_active IP Right Cessation
- 1999-04-15 IL IL129476A patent/IL129476A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SI0941252T1 (sl) | 2008-04-30 |
EP0941252A1 (fr) | 1999-09-15 |
DK0941252T3 (da) | 2008-03-31 |
CA2268865A1 (fr) | 1998-05-07 |
JP4371178B2 (ja) | 2009-11-25 |
ES2297853T3 (es) | 2008-05-01 |
PT941252E (pt) | 2008-03-07 |
BR9712575A (pt) | 1999-10-19 |
FR2755144A1 (fr) | 1998-04-30 |
JP2001502553A (ja) | 2001-02-27 |
KR20000052845A (ko) | 2000-08-25 |
NO991729D0 (no) | 1999-04-13 |
KR100874789B1 (ko) | 2008-12-18 |
HUP9904199A1 (hu) | 2000-04-28 |
NO326452B1 (no) | 2008-12-08 |
DE69738352T2 (de) | 2008-11-13 |
HU226330B1 (en) | 2008-09-29 |
IL129476A0 (en) | 2000-02-29 |
CZ145599A3 (cs) | 1999-08-11 |
SK55899A3 (en) | 2000-06-12 |
CZ300526B6 (cs) | 2009-06-10 |
US6852509B1 (en) | 2005-02-08 |
DE69738352D1 (de) | 2008-01-17 |
NO991729L (no) | 1999-04-13 |
AU4952097A (en) | 1998-05-22 |
CA2268865C (fr) | 2011-01-04 |
ATE380198T1 (de) | 2007-12-15 |
FR2755144B1 (fr) | 1998-11-27 |
WO1998018825A1 (fr) | 1998-05-07 |
ZA979738B (en) | 1998-05-22 |
HUP9904199A3 (en) | 2000-09-28 |
AU745530B2 (en) | 2002-03-21 |
IL129476A (en) | 2010-05-17 |
EP0941252B1 (fr) | 2007-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6933373B2 (en) | P53 protein variants and therapeutic uses thereof | |
JPH11511980A (ja) | Mdm2タンパク質の腫瘍原活性のアンタゴニスト及び癌治療におけるその使用 | |
SK286978B6 (sk) | Použitie jednoreťazcovej protilátky schopnej špecificky viazať epitop prítomný v C-koncovej oblasti proteínu p53 medzi zvyškami 320-393 a nukleovej kyseliny kódujúcej takúto protilátku na prípravu farmaceutickej kompozície na liečbu rakovín | |
SK283071B6 (sk) | Proteín Deltap62, jeho varianty, nukleotidové sekvencie a ich využitie | |
CA2217731A1 (en) | Modulator of neuronal cell response to inhibition by cns myelin | |
KR20230029774A (ko) | 인간화 항-emap ii 치료용 항체 | |
CA2385234A1 (en) | Nrage nucleic acids and polypeptides and uses thereof | |
MXPA97008877A (en) | P62, its variants, the nucleic acid sequences that code them, and its use in anti-cancer gene therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20121027 |